Amylyx Pharmaceuticals, Inc. (AMLX) — Cost of Revenue
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $5.95M | -76.6% |
| 2023 | $25.44M | +750.0% |
| 2022 | $2.99M | — |
| Fiscal Year | Cost of Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $5.95M | -76.6% |
| 2023 | $25.44M | +750.0% |
| 2022 | $2.99M | — |